26 minute film Safer Medicines showcases state-of-the-art approaches to ensuring that drugs in the future will be safer than they have been in the past. World leading scientists from industry and academia present their vision for the future of drug development – with a focus on human biology.
Mat Fraser, actor and Thalidomider, argues powerfully that better means to assess drug safety are needed.
Tony Benn shows that the case for a scientific evaluation of animal tests for drug safety is unarguable and should be a priority.
Randal Charlton, founder of Asterand, the world’s leading human tissue company and Dr Bob Coleman, Senior Scientific Consultant to Asterand, explain how crucial it is to focus on human tissue in drug discovery and development.
Dr Greg Baxter, co-founder of Hurel Corporation, introduces the exciting concept of microfluidics.
Dr Quin Wills, co-founder of SimuGen, explains what can be achieved with DNA chips in conjunction with advanced mathematical models of how human genes respond to drugs.
Professor Denis Noble of Oxford University and a key founder of the Physiome project shows the value of virtual organs such as the virtual heart.
Professor Colin Garner of York University and founder of Xceleron describes how microdosing offers a revolutionary approach to drug testing.
World Patient Safety Day is grounded in the most fundamental principle of medicine – first do no harm “Medication Safety” is the theme for World Patient Safety Day 2022. Safer Medicines Trust is a patient safety charity whose mission is to improve the safety of medicines, so we very much support calls for “Medication Without Harm”. The World […]The crisis of Alzheimer’s disease research: it’s time to embrace a new approach to help patients
The problem Alzheimer’s disease (AD) is a leading cause of death in the UK and along with other dementias, is responsible for almost 11% of all deaths in England.1 More than 209,000 new cases are diagnosed each year across the UK.2 It remains a leading cause of death and disability worldwide3, affecting nearly 50 million […]